MX9707638A - Vacuna de chlamydia. - Google Patents

Vacuna de chlamydia.

Info

Publication number
MX9707638A
MX9707638A MX9707638A MX9707638A MX9707638A MX 9707638 A MX9707638 A MX 9707638A MX 9707638 A MX9707638 A MX 9707638A MX 9707638 A MX9707638 A MX 9707638A MX 9707638 A MX9707638 A MX 9707638A
Authority
MX
Mexico
Prior art keywords
chlamydia vaccines
chlamydia
vaccines
immunostimulants
mpl
Prior art date
Application number
MX9707638A
Other languages
English (en)
Other versions
MXPA97007638A (es
Inventor
Jean-Paul Prieels
Moncef Mohamed Slaoui
Jean-Francois Maisonneuve
Vincent Verlant
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of MX9707638A publication Critical patent/MX9707638A/es
Publication of MXPA97007638A publication Critical patent/MXPA97007638A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una vacuna novedosa se presenta para la prevencion de infecciones de Chlamydia utilizando la proteína de membrana externa y dos inmunoestimulantes, 3D-MPL y QS21.
MXPA/A/1997/007638A 1995-04-03 1997-10-03 Vacuna de chlamydia MXPA97007638A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506863.1A GB9506863D0 (en) 1995-04-03 1995-04-03 Vaccines
GB9506863.1 1995-04-03

Publications (2)

Publication Number Publication Date
MX9707638A true MX9707638A (es) 1998-06-28
MXPA97007638A MXPA97007638A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
HUP9801572A3 (en) 1999-04-28
BR9604853A (pt) 1998-06-16
DK0820304T3 (da) 2000-08-28
JPH11503142A (ja) 1999-03-23
PT820304E (pt) 2000-11-30
ATE193974T1 (de) 2000-07-15
GR3033764T3 (en) 2000-10-31
HK1008495A1 (en) 1999-05-14
NO974561D0 (no) 1997-10-02
CN1185740A (zh) 1998-06-24
HUP9801572A2 (hu) 1998-10-28
CA2215520A1 (en) 1996-10-10
ZA962616B (en) 1996-11-27
WO1996031236A1 (en) 1996-10-10
PL322620A1 (en) 1998-02-02
NO974561L (no) 1997-11-26
AU700548B2 (en) 1999-01-07
CA2215520C (en) 2008-01-22
CZ313497A3 (cs) 1998-03-18
TR199701113T1 (xx) 1998-03-21
GB9506863D0 (en) 1995-05-24
ES2149466T3 (es) 2000-11-01
NZ306443A (en) 1999-02-25
EP0820304A1 (en) 1998-01-28
DE69608959T2 (de) 2000-11-16
DE69608959D1 (de) 2000-07-27
KR19980703666A (ko) 1998-12-05
AU5499996A (en) 1996-10-23
EP0820304B1 (en) 2000-06-21
JP2007308508A (ja) 2007-11-29

Similar Documents

Publication Publication Date Title
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
GB9506863D0 (en) Vaccines
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
DE69531793D1 (de) Immunogene zubereitungen
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
AU4450696A (en) Enhanced immunogenic vaccine
AU3552797A (en) Vaccine preparations
AU3755999A (en) Proteins that direct the secretion of virulence proteins and vaccines comprisingthem
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
GR3026385T3 (en) Temporary inactivated benzoyl peroxide, process for its preparation and use thereof
CS275210B2 (en) Nonspecific bacterial vaccine for prevention and therapy of bacterial,fungal and viral infections
MX9100273A (es) Vacunas conjugadas en forma conjunta que comprenden proteina inmunogenica,peptidos relacionados con el hiv y porciones anionicas
ZA915626B (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties
ECSP961731A (es) Vacunas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal